We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
151
DexCom
DXCM
$33.1B
$267K 0.03%
2,355
-3,740
-61% -$411K
BWACW
152
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
$263K 0.03%
2,767,546
+492,909
+22% +$24.3K
APLS
153
DELISTED
Apellis Pharmaceuticals
APLS
$259K 0.03%
5,000
-14,000
-74% -$743K
PNTM
154
DELISTED
Pontem Corporation
PNTM
$256K 0.03%
+25,283
New +$253K
HIX
155
Western Asset High Income Fund II
HIX
$355M
$243K 0.03%
50,140
TALKW
156
DELISTED
Talkspace Inc Warrant
TALKW
$239K 0.02%
3,272,814
+684,616
+26% +$99.3K
COOL
157
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
$238K 0.02%
+24,104
New +$241K
OTMO
158
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$237K 0.02%
38,899
-69,479
-64% -$374K
ISRG icon
159
Intuitive Surgical
ISRG
$139B
$237K 0.02%
894
-1,494
-63% -$364K
WQGA
160
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
$226K 0.02%
+22,200
New +$224K
RLMD icon
161
Relmada Therapeutics
RLMD
$484M
$223K 0.02%
64,011
-152,430
-70% -$1.34M
CANO.WS
162
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$222K 0.02%
1,008,091
+778,108
+338% +$675K
SOC.WS
163
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$217K 0.02%
333,868
-1,129,902
-77% -$525K
MTD icon
164
Mettler-Toledo International
MTD
$28.6B
$214K 0.02%
148
-250
-63% -$335K
AILE
165
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$210K 0.02%
+20,963
New +$208K
IQV icon
166
IQVIA
IQV
$39.8B
$209K 0.02%
1,020
-1,697
-62% -$344K
NRGV icon
167
Energy Vault
NRGV
$605M
$209K 0.02%
66,911
MAQC
168
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$208K 0.02%
+20,000
New +$208K
FOA.WS
169
DELISTED
Finance of America Companies Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
FOA.WS
$208K 0.02%
2,679,761
+575,467
+27% +$69.7K
IDXX icon
170
Idexx Laboratories
IDXX
$46.9B
$203K 0.02%
497
-830
-63% -$322K
ARYD
171
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$198K 0.02%
19,600
LCID icon
172
PUT
Lucid Motors
LCID
$2.6B
$195K 0.02%
+510
New +$56.1K
NVACR
173
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$188K 0.02%
1,090,997
-147,829
-12% -$17.1K
GCTS.WS
174
GCT Semiconductor Holding Warrants
GCTS.WS
$22.1M
$182K 0.02%
2,669,778
+288,627
+12% +$26.7K
VGASW icon
175
Verde Clean Fuels Warrant
VGASW
$761K
$175K 0.02%
1,589,524
+247,975
+18% +$41.4K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.